[34] Peduto et al. reported that ADAM9 can hydrolyze and release the ligands of epidermal growth factor receptor and fibroblast growth factor receptor on the surface of the target exfoliated cells to promote the proliferation of prostate cancer cells. Here, ADAM9 is linked to prostate carcinoma.